{
  "id": "0cbb5ec31edb",
  "type": "finding",
  "topic": "Zepbound Q4 2025 revenue",
  "summary": "Eli Lilly Q4 2025 earnings released Feb 4 2026 show Zepbound global revenue of $4,261 million",
  "content": "Eli Lilly Q4 2025 earnings were released on February 4, 2026. Zepbound Q4 2025 global revenue was $4,261 million. This represents 123% growth from Q4 2024's $1,907 million. U.S. Zepbound revenue was $4.2 billion. Zepbound is marketed in Canada, Japan, and the United States. Full year 2025 Zepbound revenue was $13,542 million. Source: Eli Lilly Q4 2025 earnings press release.",
  "sources": [
    "https://investor.lilly.com/static-files/f087574c-4046-4711-8a56-402266f2d424",
    "https://investor.lilly.com/news-releases/news-release-details/lilly-reports-fourth-quarter-2025-financial-results-and-provides"
  ],
  "confidence": 1.0,
  "question_id": 35026,
  "report_path": "",
  "created_at": "2026-02-06T18:10:33.256468Z"
}